Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

J Transl Med. 2022 Dec 13;20(1):594. doi: 10.1186/s12967-022-03766-0.

Zengwei Tang^{1

2

3

4}, Yuan Yang⁵, Wen Chen^{1

2

3

4}, Enliang Li^{1

2

3

4}, Tingbo Liang^{6

7

8

9

10}

¹ Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China.
² Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.
³ Zhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang Province, HangzhouZhejiang, 310003, China.
⁴ Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
⁵ Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
⁶ Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China. liangtingbo@zju.edu.cn.
⁷ Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China. liangtingbo@zju.edu.cn.
⁸ Zhejiang Provincial Innovation Center for the Study of Pancreatic Diseases, Zhejiang Province, HangzhouZhejiang, 310003, China. liangtingbo@zju.edu.cn.
⁹ Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China. liangtingbo@zju.edu.cn.
¹⁰ Research Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, 310003, Zhejiang, China. liangtingbo@zju.edu.cn.

No abstract available

Publication types